EP2179722A1 — Topical formation for preventing sexual transmission of viral infection
Assigned to Heinrich Pette Institute of Leibniz Institute for Experimental Virology · Expires 2010-04-28 · 16y expired
What this patent protects
The present invention relates to the prevention of sexual transmission of viral infection, in particular, HIV infection. The invention provides a pharmaceutical composition for topical administration for prevention of sexual transmission of viral infection, wherein the compositio…
USPTO Abstract
The present invention relates to the prevention of sexual transmission of viral infection, in particular, HIV infection. The invention provides a pharmaceutical composition for topical administration for prevention of sexual transmission of viral infection, wherein the composition comprises at least one compound from the class of catechins, such as epigallo-catechin-gallate (EGCG). The invention also relates to the use of at least one compound from the class of catechins for the preparation of a pharmaceutical composition formulated for topical administration for prevention of sexual transmission of viral infection. The invention further provides a method for preventing sexual transmission of viral infection.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.